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Clinical features of cats with aqueous tear deficiency: a retrospective case
series of 10 patients (17 eyes)
Abstract
Objectives
The aim of this study was to describe the clinical findings, diagnostic test results and response to therapy of
cats with Schirmer tear test 1 (STT-1) values below the reference interval.
Methods
The medical records of three institutions were searched for cats with ocular surface disease and STT-1 values/
min, confirmed at two or more separate visits.
Results
Ten cats (17 eyes) were included. The mean ± SD (range) age and STT-1 values in affected eye(s) were 6.1 ±
5.7 (0.2–16) years and 2.4 ± 3.1 (0–8) mm/min, respectively. Concurrent ocular surface disease was bilateral
in 5/10 cats. Clinical signs included conjunctivitis (14/17 eyes), corneal ulceration (6/17 eyes), non-
ulcerative keratitis (4/17 eyes), symblepharon (4/17 eyes), eosinophilic keratitis (3/17 eyes), corneal
sequestrum (3/17 eyes), corneal fibrosis (2/17 eyes) and meibomitis (2/17 eyes). Management included
topically applied lacrimomimetics, antiviral drugs, corticosteroids or immunomodulatory drugs; orally
administered famciclovir; or surgical procedures, in various combinations. Response to therapy (defined as an
increase in STT-1 value of ⩾5 mm/min) was transient (seen at a single reassessment) in 65% of eyes and
sustained (seen at ⩾2 consecutive reassessments) in 18% of eyes.
Conclusions and relevance
Clinical features seen in cats with low STT-1 values are described, although the association between aqueous
deficiency and the reported ocular changes is unknown at this time. We encourage clinicians to assess the tear
film in cats with ocular surface disease, and initiate therapy with lacrimomimetics if STT-1 values are
repeatedly below normal. Such information will further define aqueous tear deficiency in cats, providing a
better understanding of disease prevalence, pathogenesis and treatment.
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Abstract 
Objectives - To describe the clinical findings, diagnostic test results, and response to therapy of cats with Schirmer 
tear test-1 (STT-1) values below reference range. 
Methods - The medical records of three institutions were searched for cats with ocular surface disease and STT-1 
values < 9 mm/min, confirmed at ≥ 2 separate visits.  
Results - Ten cats (17 eyes) were included. The mean ± standard deviation (range) age and STT-1 values in affected 
eye(s) were 6.1 ± 5.7 (0.2-16) years and 2.4 ± 3.1 (0-8) mm/min, respectively. Concurrent ocular surface disease was 
bilateral in 5/10 cats. Clinical signs included conjunctivitis (14/17 eyes), corneal ulceration (6/17 eyes), nonulcerative 
keratitis (4/17 eyes), symblepharon (4/17 eyes), eosinophilic keratitis (3/17 eyes), corneal sequestrum (3/17 eyes), 
corneal fibrosis (2/17 eyes), and meibomitis (2/17 eyes). Management included topically applied lacrimomimetics, 
antiviral drugs, corticosteroids, or immunomodulatory drugs; orally administered famciclovir; or surgical procedures 
in various combinations. Response to therapy (defined as an increase in STT-1 value of ≥ 5 mm/min) was transient 
(seen at a single reassessment) in 65% eyes and sustained (seen at ≥ 2 consecutive reassessments) in 18% eyes.  
Conclusions and relevance – Clinical features seen in cats with low STT-1 values are described, although the 
association between aqueous deficiency and the reported ocular changes is unknown at this time. We encourage 
clinicians to assess the tear film in cats with ocular surface disease, and initiate therapy with lacrimomimetics if STT-
1 values are repeatedly below normal. Such information will further define aqueous tear deficiency in cats, providing 
a better understanding of disease prevalence, pathogenesis, and treatment. 
  
Introduction 
Ocular surface diseases such as conjunctivitis, corneal ulceration, corneal sequestrum, and eosinophilic 
keratitis are among the most common disorders recognized in cats with ophthalmic complaints.1 Due to the intimate 
relationship between the ocular surface and the tear film, it is possible that tear film deficiency is a serious co-morbidity 
in many of these clinical presentations, as is the case in dogs2 and humans.3 In fact, a qualitative tear deficiency - or 
alteration in the mucin and/or lipid component of the tears - is often recognized in cats infected with feline herpesvirus 
type-1,4 and those with spontaneous ulcerative keratitis,5 corneal sequestrum,6 and conjunctivitis.7 
In contrast, quantitative tear deficiency – i.e., a reduction in the aqueous portion of the tears – is seldom 
reported in cats. Although the paucity of feline reports may be due to low disease prevalence, aqueous deficiency may 
also be under-recognized in this species because veterinarians are primed to look for a syndrome similar to that seen 
in dogs with keratoconjunctivitis sicca (KCS) or “dry eye”, or because testing the aqueous tear film was long assumed 
to be unreliable in cats because it could be artifactually lowered due to stress.4  Recently, normative data for the 
Schirmer tear test 1 (STT-1) and other diagnostic tests for assessment of the tear film were established in healthy cats,8 
and a case report showed that aqueous tear dysfunction in a cat was associated with chronic keratitis, conjunctivitis, 
and impaired healing of corneal ulcers.9 
The purpose of the present report, therefore, is to describe the clinical findings of a series of cats in which 
STT-1 values were below the reference range.8 In so-doing we aim to encourage veterinarians to be more alert to the 
potential role of tear deficiency and the value of tear testing in cats with various ocular surface diseases. This, in turn, 
will enhance understanding of tear deficiency in cats and power prospective, case-controlled studies designed to better 
define the clinical appearance, establish the pathogenesis, and assess therapeutic protocols for dry eye disease in this 
species.  
 
Material and methods 
Medical records of Iowa State University’s Lloyd Veterinary Medical Center (ISU-LVMC), the University of 
California-Davis’ Veterinary Medical Teaching Hospital (UCD-VMTH), and Triangle Animal Eye Clinic (TAEC) in 
Tokyo, Japan were searched from 2006-2018 for cats with unilateral or bilateral ocular surface disease and STT-1 
values < 9 mm/min8 at presentation and on at least one subsequent examination. Signalment, ocular abnormalities, 
diagnostic test results, and management strategies were retrieved from the medical records. Response to therapy was 
defined as an increase in STT-1 value of ≥ 5 mm/min,10, 11 and was further defined as “transient” or “sustained” if the 
improvement was noted at 1 or  ≥ 2 consecutive follow-up visits, respectively. 
 
Results 
Animals – Seventeen eyes of 10 cats met all inclusion criteria (Table 1). The mean ± standard deviation (range) age, 
body weight and STT-1 values in affected eye(s) were 6.1 ± 5.7 (0.2-16) years, 4.3 ± 1.9 (0.6-6.7) kg, and 2.4 ± 3.1 
(0-8) mm/min, respectively. Ocular surface disease was bilateral in 5 cats, one of which (Case 6) had a STT-1 value 
< 9 mm/min in only one eye.  Disease was unilateral in the other 5 cats, three of which (Cases 4, 9, and 10) had STT-
1 values < 9 mm/min in both eyes.  
Clinical diagnoses – Concurrent ocular surface pathology included conjunctivitis (14 eyes), corneal ulceration (6), 
nonulcerative keratitis (4), symblepharon (4), eosinophilic keratitis (3), corneal sequestrum (3), corneal fibrosis (2), 
or meibomitis (2). Other ocular abnormalities seen included uveitis (3 eyes), glaucoma (1), iris hyperpigmentation (1), 
or retrobulbar abscess (1). The ocular surface was described as ‘lackluster’ in 10/17 affected eyes, and 3 cats had mild 
crusted discharge at the medial canthus (Figure 1). 
Diagnostic testing – The STT-1 was performed in all eyes; mean ± standard deviation (range) value in affected eyes 
was 2.4 ± 3.1 (0-8) mm/min. The phenol red thread test (PRTT) was performed in Cases 1-4 and was within normal 
limits (≥ 15mm/15sec)8 in all affected eyes but one (Case 2) despite these eyes all having low STT-1 values (Table 
2). Corneal sensitivity was estimated using a Cochet-Bonnet aesthesiometer in four eyes (Cases 5 and 10) and was 
markedly reduced in all 3 affected eyes (Table 2).12 Tear film breakup time (TFBUT) was performed in Case 5 only 
and was decreased bilaterally at 5-7 seconds. Fluorescein and rose bengal staining, corneal cytology, conjunctival 
histology and various infectious disease tests were completed in some cats (Tables 2 and 3). 
Therapy – A wide range of management techniques was used throughout the clinical course of the 10 cats (Table 1). 
Topically applied lacrimomimetic agents were used in 15 eyes (10 cats) for between 14 and 628 days from 1-12 times 
daily depending on the severity of clinical signs. Most lacrimomimetic agents prescribed contained sodium 
hyaluronate; 5 eyes (4 cats) with severe aqueous deficiency also received autologous serum. Corticosteroids were 
applied topically in 5 eyes (4 cats) 1-3 times daily for 9-309 days. Other topical immunomodulatory drugs were used 
in 4 eyes (3 cats) for 35-244 days; these included 0.03% tacrolimus ophthalmic ointment (2 eyes), 0.2% cyclosporine 
ophthalmic ointment (1 eye), or 1% (1 eye) or 2% (1 eye) cyclosporine ophthalmic suspension compounded in corn 
oil. Both cats that received cyclosporine compounded in corn oil developed blepharitis. Famciclovir was prescribed 
in 7 cats for 22-294 days at doses of 35-50 mg/kg three times daily (4 cats), 86-90 mg/kg twice daily (2 cats) or 100 
mg/kg once daily (1 cat). Topical antiviral drugs were prescribed in 4 eyes (4 cats) for 109-366 days; these included 
0.5% cidofovir ophthalmic solution applied twice daily (3 eyes) or 0.1% idoxuridine ophthalmic solution applied 4-6 
times daily (1 eye). Surgical procedures included bilateral dissection of symblepharon (Case 2), thermokeratoplasty 
for a non-healing ulcer (Case 5), or corneoconjunctival transposition following a lamellar keratectomy for sequestrum 
removal (Case 6). Other therapies included topically or systemically administered antibiotics, systemically 
administered corticosteroids, or warm compresses applied to the eyelids (Table 1). 
Response to therapy - Mean ± standard deviation (range) follow-up time was 383 ± 320 (63-994) days. Complete 
resolution of clinical signs was documented in 3 cats (Cases 4, 5, and 9), whereas partial clinical improvement was 
noted in 5 cats (Cases 1, 2, 3, 7, and 8). At the last recheck examination, keratoconjunctivitis was still present in the 
remaining 2 cats (Cases 6 and 10). Figure 2 depicts representative images from follow-up examinations of Cases 2, 4, 
5, and 8.  The STT-1 value increased by ≥ 5 mm/min in 14/17 affected eyes; this increase was transient (seen at a 
single reassessment) in 11 (65%) of affected eyes and sustained (seen at ≥ 2 consecutive reassessments) in 3 (18%) of 
affected eyes. 
 
Discussion 
This report describes clinical signs of ocular surface disease in a series of 10 cats (17 eyes) with aqueous tear 
deficiency (STT-1 value < 9 mm/min). Although the association between aqueous tear deficiency and ocular surface 
disease is unknown based on this case series, tear film dysfunction would be expected to have a detrimental effect on 
the ocular surface health of cats, similar to dogs and humans. Conversely, ocular surface diseases may have a negative 
effect on tear production and perpetuate dry eye. A STT-1 value < 9 mm/min (especially when confirmed on two 
separate occasions as required in this case series) should be considered abnormal in cats as the occurrence of low STT-
1 values in ophthalmically normal cats is rare.8, 13 Indeed, Paepe and colleagues found that only 2/100 normal cats had 
STT-1 values < 5 mm/min,13 while Sebbag and colleagues showed that 0/135 normal cats had STT-1 values < 7 
mm/min.8 In addition to STT-1, the PRTT was also measured in 4 cats (8 eyes) but was normal in all but one affected 
eye. This supports previous data suggesting that the PRTT is less reliable than the STT-1 in cats.8 For this reason, and 
because the STT-1 provides a measure of basal and reflex tearing as well as a coarse assessment of the neurologic 
function essential for a normal lacrimal functional unit,14 these authors prefer using the STT-1 than the PRTT to assess 
the aqueous tear film in cats.  Once reduced aqueous tear film is documented, vital stains such as fluorescein, rose 
bengal, or lissamine green can be particularly helpful in highlighting subtle changes in the corneal and/or conjunctival 
surfaces.15 Finally, corneal aesthesiometry is an essential diagnostic tool in cats in which neurologic dysfunction is 
suspected, as exemplified by Cases 5 and 10 of this report and a cat from a previous report9 in which corneal 
hypoesthesia  likely contributed to their aqueous tear deficiency. By contrast, tear osmometry has not proven as reliable 
or helpful in dogs16 or cats8, 17 as it has in humans3 with tear film deficiency. 
Impaired tear production or release, or hastened tear loss, especially through evaporation should all be 
considered as potential causes for low STT-1 values. In some cats of the present series, impaired tear secretion onto 
the ocular surface because of obstructed lacrimal ductules seems likely to have contributed to the aqueous tear 
deficiency noted. This may be a transient consequence of conjunctival swelling as a result of conjunctivitis (as seen 
in many cases in the present study) or orbital cellulitis, or a more permanent consequence of adhesions from 
symblepharon or eyelid agenesis18 (as seen in Cases 1 and 2 herein). Where possible, correction of these underlying 
causes may normalize STT-1 values. This is likely what happened in Case 8 in which successful treatment of the 
retrobulbar abscess was associated with a sustained increase in STT values. A neurogenic cause of aqueous tear 
deficiency should also be considered in cats. This is a recognized etiology in dogs19 and humans20 and has been 
reported in one cat.9 Humans with chronic inflammation from herpes simplex virus-1 infection experience permanent 
damage to the trigeminal nerve with subsequent corneal hypoesthesia and decreased reflex tearing.21  Although 
multiple causes of neurogenic dry eye exist, the high prevalence of herpetic disease in cats warrants consideration and 
further investigation of a metaherpetic form of dry eye disease, as described in humans. 
In all cases of dry eye disease, absence of a confirmed etiologic diagnosis renders therapy challenging – as 
evident in the present case series. In such cases, therapy is limited to hydrating and lubricating the ocular surface with 
lacrimomimetic agents, and controlling concurrent ocular surface inflammation. This likely explains the generally 
poor responses observed in the cases presented here and highlights the need for future studies to determine the 
etiopathogenesis of qualitative and quantitative tear film deficiency in cats. We hope this report will heighten feline 
practitioners’ awareness of the importance of performing the STT-1 in this species so that future studies might 
establish a more comprehensive definition of feline dry eye that better elucidates disease prevalence, clinical features, 
pathogenesis, and therapeutic strategies. Such studies should include larger cohorts than reported here, and inclusion 
of a control population in order to better understand the pathogenic role of tear film deficiency in feline ocular surface 
disease. 
 
Conclusions 
Aqueous tear deficiency can occur concurrently with common ocular surface diseases in cats. Although the causative 
association between aqueous tear deficiency and these diseases is not known, experience in other species suggests that 
tear film deficiencies would be, at the very least, contributory. We encourage clinicians to perform STT-1 in cats with 
ocular surface disease, and to initiate therapy with lacrimomimetics if tear film dysfunction is noted. Complementary 
tests such as vital stains, TFBUT, and corneal aesthesiometry can provide valuable information about the nature and 
sometimes the cause of the tear film deficiency, as well as the extent of ocular surface damage. Such data will facilitate 
a deeper understanding of the prevalence and pathogenesis of, diversity of clinical signs associated with, and response 
to therapy in cats with qualitative and quantitative tear film deficiencies. 
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Table 1. Summary information for 10 cats with reduced aqueous tear film (Schirmer tear test 1 < 9 mm/min) and concurrent ocular surface disease seen at the Triangle Animal Eye Clinic 
(TAEC), University of California-Davis Veterinary Medical Teaching Hospital (UCD VMTH), or Iowa State University’s Lloyd Veterinary Medical Center (ISU LVMC). STT-1 = 
Schirmer tear test 1; mo= month old; yo=year old; DSH= domestic short hair; DLH = domestic long hair; M = male; F = female; I = intact; S = spayed; N = neutered; OD = right eye; 
OS = left eye; OU = both eyes. 
 
Case # Signalment Clinic at which seen Concurrent ocular disease All therapies used throughout clinical course 
Follow-up 
(days) Clinical outcome 
1 2 mo MI DSH TAEC Symblepharon OU 
Conjunctivitis OU 
Nonulcerative keratitis OU  
 
Sodium hyaluronate ophthalmic solution, oral famciclovir 63 Improved corneal transparency OU 
Improved conjunctivitis OU 
 
2 5 mo FI DSH TAEC Symblepharon OU 
Conjunctivitis OU 
Nonulcerative keratitis OU 
 
Sodium hyaluronate ophthalmic solution, 0.5% erythromycin; 
oral famciclovir; symblepharon dissection; warm compresses 
 
135 Improved keratoconjunctivitis OU 
Static symblepharon OU 
 
3 7 yo FS 
Abyssinian 
TAEC Corneal sequestrum OS 
Conjunctivitis OS 
Sodium hyaluronate ophthalmic solution, 0.5% erythromycin, 
0.3% ofloxacin; oral famciclovir, warm compresses 
 
331 Improved conjunctivitis OS 
 
4 4 yo MN 
Russian Blue 
TAEC Eosinophilic keratitis OS 
Conjunctivitis OS 
Sodium hyaluronate ophthalmic solution, 1% prednisolone 
acetate, 0.5% erythromycin; oral famciclovir, doxycycline 
 
309 Resolved keratitis OS 
 
 
5 16 yo MN DSH UCD VMTH Non-healing corneal ulcer OU 
Anterior uveitis OU 
Conjunctivitis OD 
Corneal fibrosis OD 
Glaucoma OD 
 
Sodium hyaluronate ophthalmic solution, serum, 2% 
dorzolamide /0.5% timolol, 0.005% latanoprost; oral 
famciclovir, prednisolone; corneal debridement; 
thermokeratoplasty 
431 Resolved corneal ulceration OU 
Residual corneal fibrosis and 
neovascularization OD 
 
 
 
6 9 yo FS Maine 
Coon 
UCD VMTH Corneal sequestrum OU 
Conjunctivitis OU 
Meibomitis OU 
Eosinophilic keratitis OD 
Ulcerative keratitis OS 
Corneal fibrosis OS 
 
Sodium hyaluronate ophthalmic solution, 0.5% cidofovir, 0.2% 
cyclosporine, 0.3% tobramycin, 0.3% ciprofloxacin, 0.3% 
ofloxacin; oral famciclovir, L-lysine; corneo-conjunctival 
transposition 
994 Resolved ulcerative keratitis OS 
Recurrence of eosinophilic keratitis OD 
7 18 mo MN DSH UCD VMTH Descemetocele OU 
Conjunctivitis OU 
Corneal fibrosis OS 
 
Sodium hyaluronate ophthalmic solution, serum, neomycin-
polymyxin B-dexamethasone, 0.1% idoxuridine, 2% 
cyclosporine, 0.03% tacrolimus, 0.3% ciprofloxacin; oral 
prednisolone, azithromycin; warm compresses 
 
922 Nonulcerative keratitis OU 
8 14 mo FI Maine 
Coon 
UCD VMTH Retrobulbar abscess OD 
Conjunctivitis OD 
Ulcerative keratitis OD 
Anterior uveitis OD 
 
Sodium hyaluronate ophthalmic solution, serum, 5.5% 
cefazolin, 0.3% ciprofloxacin; oral amoxicillin/clavulanic acid, 
prednisolone 
241 Resolved retrobulbar disease OD 
Resolved conjunctivitis OD 
Active keratitis OD 
 
9 14 yo FS DSH ISU LVMC Ulcerative keratitis OD 
Conjunctivitis OD 
Sodium hyaluronate ophthalmic solution, serum, 0.1% 
dexamethasone, 0.5% cidofovir, 1% cyclosporine, 0.3% 
tobramycin, 1% atropine; oral famciclovir; corneal 
debridement; bandage contact lens 
 
187 Resolved keratoconjunctivitis OD 
10 8 yo FS DLH ISU LVMC Eosinophilic keratitis OD 
Conjunctivitis OD 
Iris hyperpigmentation OD 
Sodium hyaluronate ophthalmic solution, 1% prednisolone 
acetate, 0.5% cidofovir; oral L-lysine; corneal debridement 
217 Active keratitis OD 
Static iris hyperpigmentation OD 
Table 2. Results of tear film diagnostic tests and corneal aesthesiometry in 10 cats with aqueous tear deficiency (Schirmer tear test 1 < 9 mm/min) and concurrent ocular surface 0 
disease. Results are depicted as “right eye / left eye” and describe findings at the first visit except when mentioned otherwise in the column header. The lower reference limit (LRL) 1 
is noted for each test in the column header.  STT-1 = Schirmer tear test 1; PRTT = Phenol red thread test; TFBUT = Tear film break up time; CTT = Corneal touch threshold; + = 2 
present; OD = right eye; OS = left eye. 3 
 4 
Case # Ocular surface disease present 
STT-1  
(LRL = 9 mm/min)8 
 STT-1 at last visit 
(LRL = 9 mm/min)8 
PRTT  
(LRL = 15 mm/15sec)8 
TFBUT  
(LRL = 9.1 sec)8 
CTT 
 (LRL = 3.0 cm)12 
Corneal 
fluorescein 
stain retention  
Corneal rose 
bengal stain 
retention  
 
1 
 
 
+ / + 
 
2 / 0 
 
7 / 5 
 
26 / 30     
2 
 + / + 0 / 0 0 / 5 19 / 11     
3 
 - / + 10 / 1 14 / 10 31 / 29   + / + + / + 
4 
 - / + 3 / 7 10 / 5 20 / 22   + / + - / + 
5 
 +/+ 0 / 0 0 / 0  5-7 / 5 0 / 1 + / -  
6 
 +/+ 0 / 19 13/ 20    - / +  
7 
 +/+ 0 / 0 15 / 0    -  / +  
8 
 +/- 0 / 15 9 /17    + / -  
9 
 +/- 5 / 8 9 / 11    + / -  
10 
 +/- 7 / 7 8 / 6   0.5 / 3 + / -  
 5 
  6 
 7 
Table 3. Results of additional diagnostic tests performed in 10 cats with aqueous tear deficiency (Schirmer tear test 1 < 9 mm/min) and concurrent ocular surface disease. FHV-1 = 8 
Feline herpesvirus type-1; FCV = Feline calicivirus; FeLV Ag = Feline leukemia virus antigen; FIV Ab = Feline immunodeficiency virus antibodies. 9 
 10 
Case #  Eye tested Corneal cytology Conjunctival histopathology Infectious disease testing 
4 Left Eosinophilic, neutrophilic, and lymphocytic inflammation   
Nucleic acids of FHV-1, FCV, Mycoplasma felis, 
Chlamydia felis, and Bordetella bronchiseptica not 
detected in corneo-conjunctival swab  
5      FeLV Ag and  FIV Ab not detected in serum 
6 Right Eosinophilic inflammation 
Severe chronic lymphocytic, 
plasmacytic and neutrophilic 
conjunctivitis 
  
8 Right Neutrophilic inflammation with squamous cell melanosis     
10 Right Eosinophilic inflammation     
11 
Figures and Figure legends 12 
Figure 1. Clinical photographs of eyes of 10 cats at time of presentation for ocular surface disease and concurrent 13 
aqueous tear deficiency (Schirmer tear test 1 < 9 mm/min). Case numbers are shown in the top left and Schirmer tear 14 
test-1 values in the bottom right of each image. Abnormalities included symblepharon (Cases 1 and 2), corneal 15 
sequestrum (Cases 3 and 6), eosinophilic keratitis (Cases 4 and 10), non-healing corneal ulceration (Case 5), ulcerative 16 
keratitis (Case 9), conjunctivitis (Case 7), and retrobulbar abscess (Case 8).  17 
 18 
Figure 2. Clinical photographs of eyes of 4 cats at time of follow-up following therapy for ocular surface disease and 19 
concurrent aqueous tear deficiency (Schirmer tear test 1 < 9 mm/min). See Figure 1 for appearance at presentation.  20 
Case numbers are shown in the top left and Schirmer tear test-1 values in the bottom right of each image. Keratitis in 21 
Case 2 improved but symblepharon was static (Day 135). Eosinophilic keratitis resolved in Case 4 (Day 309). Corneal 22 
ulceration resolved in Case 5 but there was residual corneal fibrosis and neovascularization (Day 305). 23 
Keratoconjunctivitis improved in Case 8 following resolution of the retrobulbar abscess (Day 120). 24 
 25 
 26 
